Stay updated on Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record now indicates that recruitment is closed and no longer looking for participants. Additionally, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was reformatted, and the revision version updated to v3.6.0.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, reflecting an editorial update to the page metadata.SummaryDifference0.1%

- Check36 days agoChange DetectedNew Revision: v3.5.4 appears on the page, replacing the old v3.5.3 tag. This is a minor metadata update to the page, not altering the study content or results.SummaryDifference0.1%

- Check58 days agoChange DetectedUpdated the site’s displayed release/revision version from **v3.5.2** to **v3.5.3** at the bottom of the page.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed. This update reflects backend versioning and does not change visible content or functionality.SummaryDifference0.1%

Stay in the know with updates to Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.